French, US Partners to Use Artificial Intelligence to Predict Cancer Treatment Response – Immuno-Oncology News
Immuno-Oncology News |
French, US Partners to Use Artificial Intelligence to Predict Cancer Treatment Response
Immuno-Oncology News Freenome has been using machine learning to look beyond tumor DNA to improve cancer detection. The South San Francisco-based company has created a growing database of cell-free cancer biomarkers. It uses them to develop blood tests for early detection … |
